Article
Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
Bioengineered - 3 Sept 2017
Mousavi Ardehaie Reza, Hashemzadeh Shahriar, Behrouz Sharif Shahin, Ghojazadeh Morteza, Teimoori-Toolabi Ladan, Sakhinia Ebrahim
Abstract excerpt
Cancers are among the most serious threats of human health worldwide. Survival and mortality rates of colorectal cancer (CRC) strongly depend on the early diagnosis. The aberrant methylation pattern of genes as a diagnostic biomarker can serve as a practical option for timely detection and contribute subsequently to the enhancement of survival rate in CRC patients, since methylation changes are not only frequent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.